New drug for use in bone scans approved
Links shared publicly online about this topic.
- 538total visits
New drug for use in bone scans approved
View full resource at physorg.com
Tags: Cancer, Bone, Sodium, Drug, Healthy Living, FDA, National Institutes of Health
Most Recently Shared on February 1, 2011 at 6:49 pm By:
New drug for use in bone scans approved http://bit.ly/fJ6Nrf
FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
drugs.com — “Prolia (denosumab) is used in the treatment of bone loss in patients with prostate or breast cancer undergoing hormone ablation therapy. Includes Prolia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 20, 2011 at 1:04 am By:
Drugs and Devices OW OW Health
FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prosta... http://t.co/vescEIgy #drug
FDA clears Amgen bone drug for cancer patients | Reuters
reuters.com — “WASHINGTON (Reuters) - U.S. drug regulators approved two new uses for Amgen Inc's osteoporosis drug Prolia, allowing it to be used for bone loss associated with certain cancer treatments.The Food and” View full resource at reuters.com
Most Recently Shared on September 19, 2011 at 7:37 pm By:
Hisham Rana, MD Doctor and Physician
News: U.S. FDA clears Amgen bone drug for cancer patients http://t.co/MR0ALdM9 - #health #pharma
NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome
medicalnewstoday.com — “A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a ra” View full resource at medicalnewstoday.com
Most Recently Shared on September 6, 2011 at 7:05 am By:
MNT Cervical Cancer Health News
NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome http://mnt.to/3Zqx #cervicalcancer #hpv
To treat rare immune deficiency disease, scientists repurpose bone marrow transplant drug
sciencedaily.com — “A new study reports that a drug already approved by the U.S. Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome. People with the syndrome are more susceptible to potentially life-threatening bacterial and viral infections, particularly human papillomavirus infections, which cause skin and genital warts and can lead to cancer.” View full resource at sciencedaily.com
Most Recently Shared on September 4, 2011 at 7:30 am By:
To treat rare immune deficiency disease, scientists repurpose bone marrow transplant drug: A new study reports t... http://t.co/tg993MU
Plerixafor drug shows promise against WHIM syndrome
news-medical.net — “A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome.” View full resource at news-medical.net
Most Recently Shared on September 3, 2011 at 6:22 am By:
Plerixafor drug shows promise against WHIM syndrome: A new study reports that a drug already approved by the Foo... http://t.co/MJAaM83
To treat rare disease, NIH scientists repurpose FDA-approved drug
medicalxpress.com — “A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome. People with the syndrome are more susceptible to potentially ...” View full resource at medicalxpress.com
Most Recently Shared on September 2, 2011 at 2:54 pm By:
PhysOrg Health News Health News
To treat rare disease, NIH scientists repurpose FDA-approved drug http://t.co/rmv9NJm
Symposier - MRI Compatible Pacemaker
symposier.com — “Uploaded and shared in Youtube by: orlandohealth --" Orlando Regional Medical Center is the first hospital in Florida to implant a new pacemaker designed for safe use during magnetic resonance imaging (MRI) scans often used to diagnose and treat conditions. Recently approved by the U.S. Food and Drug Administration, the Revo MRI™ SureScan® pacing system by Medtronic, is the first and only pacemaker in the U.S. specifically designed for use in an MRI environment and approved as MR-Condi” View full resource at symposier.com
Most Recently Shared on March 30, 2011 at 5:35 pm By:
Symposier Cardiology Health Business and Cardiology
MRI Compatible Pacemaker implanted at Orlando Regional Medical Center. http://bit.ly/fQsFRL
FDA approves new dose of sodium fluoride for bone scans - - Drug Topics
drugtopics.modernmedicine.com — “After its withdrawal from the marketplace 35 years ago, sodium fluoride F 18 for use in bone scans is experiencing a rebirth as a result of a New Drug Application submitted by the National Cancer Institute and approved by FDA.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on February 9, 2011 at 7:12 pm By:
Drugs and Devices OW OW Health
FDA approves new dose of sodium fluoride for bone scans: After its withdrawal from the marketplace 35 years ago,... http://bit.ly/feisAL
New Drug for Use in Bone Scans Approved - National Cancer Institute
cancer.gov — “The FDA has approved a New Drug Application (NDA) from NCI for a new strength of a previously approved drug, Sodium Fluoride F18, for use in bone scans. In contrast to Technetium-99m, which has been the only approved radioactive tracer for bone scans, Sodium Fluoride F18 is not subject to the supply problems.” View full resource at cancer.gov
Most Recently Shared on February 2, 2011 at 3:43 pm By:
NCI news: FDA has approved an NDA from NCI, providing alternative to radioactive tracer in short supply http://j.mp/eHHQnS
FDA approves NCI's Sodium Fluoride F18 NDA for use in bone scans
news-medical.net — “The FDA has approved a New Drug Application from the National Cancer Institute, part of the National Institutes of Health, for a new strength of a previously approved drug, Sodium Fluoride F18, for use in bone scans.” View full resource at news-medical.net
Most Recently Shared on February 2, 2011 at 9:10 am By:
Medicare News: FDA approves NCI's Sodium Fluoride F18 NDA for use in bone scans: The FDA has approved a New Drug... http://bit.ly/gtwW7E
Clinical grade stem cells to be manufactured by Stemedica as it awaits FDA approval of an IND to commence clinical trials
news-medical.net — “Stemedica Cell Technologies, Inc. USA, a leader in adult stem cell research and manufacturing, has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration ("FDA") to discuss a proposed IND to use Stemedica's proprietary line of allogeneic mesenchymal bone marrow cells (adult human) as a treatment for ischemic stroke.” View full resource at news-medical.net
Most Recently Shared on August 21, 2009 at 1:57 pm By:
Stroke News: Clinical grade stem cells to be manufactured by Stemedica as it awaits FDA approval of .. http://twurl.nl/b37v3n
Advertisement
